Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Nanotechnology
|
December 8, 2018
Enhanced interaction in TiO<sub>2</sub>/BiVO<sub>4</sub> heterostructures via MXene Ti<sub>3</sub>C<sub>2</sub>-derived 2D-carbon for highly efficient visible-light photocatalysis
Liang Shi, Chonglei Xu, Daixun Jiang, et al.
International Journal of Molecular Medicine
|
August 15, 2018
Long noncoding RNA cancer susceptibility candidate 9 promotes doxorubicin‑resistant breast cancer by binding to enhancer of zeste homolog 2
Baohong Jiang, Yuehua Li, Xiaofei Qu, et al.
Scientific Reports
|
April 9, 2025
Implementation of double Feynman gate in high dimensional quantum systems
Yanbing Zhu, Jiaqi Shang, Ya-Nan Fan, et al.
International Journal of Cancer
|
March 17, 2021
Novel functional variants in the Notch pathway and survival of Chinese colorectal cancer
Xiaofei Qu, Liqin Zhao, Mengyun Wang, et al.
Radiation Research
|
September 20, 2016
PIDD Mediates Radiation-Induced Microglia Activation
Nong Yang, Xican Gao, Xiaofei Qu, et al.
Colloids and Surfaces. B, Biointerfaces
|
December 22, 2022
Fabrication and properties of multi-functional polydopamine coated Cu/F-codoped hydroxyapatite hollow microspheres as drug carriers
Xiaodan Jiang, Xiaowei Liu, Jiayi Cai, et al.
Biochemical and Biophysical Research Communications
|
May 25, 2018
Long non-coding RNA MIAT is estrogen-responsive and promotes estrogen-induced proliferation in ER-positive breast cancer cells
Yuehua Li, Baohong Jiang, Xiaoping Wu, et al.
Cancer Medicine
|
August 11, 2020
Predictive model for risk of gastric cancer using genetic variants from genome-wide association studies and high-evidence meta-analysis
Lixin Qiu, Xiaofei Qu, Jing He, et al.
Oncology and Therapy
|
September 14, 2025
First-Line Tislelizumab Plus Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer: PD-L1 ≥ 50% Subgroup Analysis from the RATIONALE-304 Trial
Shun Lu, Jie Wang, Yan Yu, et al.
Cancer Chemotherapy and Pharmacology
|
October 8, 2025
A phase I study of the OX40 agonist BGB-A445 with or without tislelizumab, an anti-PD-1 monoclonal antibody, in patients with advanced solid tumors: dose-escalation results
Jayesh Desai, Sanjeev Deva, Bo Gao, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Nanotechnology
|
December 8, 2018
Enhanced interaction in TiO<sub>2</sub>/BiVO<sub>4</sub> heterostructures via MXene Ti<sub>3</sub>C<sub>2</sub>-derived 2D-carbon for highly efficient visible-light photocatalysis
Liang Shi, Chonglei Xu, Daixun Jiang, et al.
International Journal of Molecular Medicine
|
August 15, 2018
Long noncoding RNA cancer susceptibility candidate 9 promotes doxorubicin‑resistant breast cancer by binding to enhancer of zeste homolog 2
Baohong Jiang, Yuehua Li, Xiaofei Qu, et al.
Scientific Reports
|
April 9, 2025
Implementation of double Feynman gate in high dimensional quantum systems
Yanbing Zhu, Jiaqi Shang, Ya-Nan Fan, et al.
International Journal of Cancer
|
March 17, 2021
Novel functional variants in the Notch pathway and survival of Chinese colorectal cancer
Xiaofei Qu, Liqin Zhao, Mengyun Wang, et al.
Radiation Research
|
September 20, 2016
PIDD Mediates Radiation-Induced Microglia Activation
Nong Yang, Xican Gao, Xiaofei Qu, et al.
Colloids and Surfaces. B, Biointerfaces
|
December 22, 2022
Fabrication and properties of multi-functional polydopamine coated Cu/F-codoped hydroxyapatite hollow microspheres as drug carriers
Xiaodan Jiang, Xiaowei Liu, Jiayi Cai, et al.
Biochemical and Biophysical Research Communications
|
May 25, 2018
Long non-coding RNA MIAT is estrogen-responsive and promotes estrogen-induced proliferation in ER-positive breast cancer cells
Yuehua Li, Baohong Jiang, Xiaoping Wu, et al.
Cancer Medicine
|
August 11, 2020
Predictive model for risk of gastric cancer using genetic variants from genome-wide association studies and high-evidence meta-analysis
Lixin Qiu, Xiaofei Qu, Jing He, et al.
Oncology and Therapy
|
September 14, 2025
First-Line Tislelizumab Plus Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer: PD-L1 ≥ 50% Subgroup Analysis from the RATIONALE-304 Trial
Shun Lu, Jie Wang, Yan Yu, et al.
Cancer Chemotherapy and Pharmacology
|
October 8, 2025
A phase I study of the OX40 agonist BGB-A445 with or without tislelizumab, an anti-PD-1 monoclonal antibody, in patients with advanced solid tumors: dose-escalation results
Jayesh Desai, Sanjeev Deva, Bo Gao, et al.
Page
of 3